|
|
||||||||







,
,
,
* Institut National de la Santé et de la Recherche Médicale, Unité 503, LInstitut Fédératif de Recherche 128 BioSciences Lyon-Gerland, and
Université Claude Bernard Lyon 1, Lyon, France;
Hospices Civils de Lyon, Department of Clinical Immunology and Allergy, Centre Hospitalier Universitaire de Lyon Sud, Pierre Bénite, France; and
Institut de Recherche Pierre Fabre, Hôtel Dieu St-Jacques, Toulouse, France
Skin lesions in the allergic form of atopic dermatitis (AD) are induced by allergen-specific T cells that infiltrate the skin at the site of allergen exposure. Although Th2-type CD4+ T cells appear to be crucial in AD pathophysiology, little is known about the contribution of CD8+ T cells in the development of the allergic skin inflammation. In the present study, we have analyzed the respective role of CD8+ and CD4+ T cells in the development of AD skin lesions in a mouse model of allergen-induced AD. In sensitized mice, CD8+ T cells are rapidly and transiently recruited to the allergen-exposed site and initiate the inflammatory process leading to skin infiltration with eosinophils and Th1/Th2-producing cells. CD8+ T cell-depleted mice show no inflammation, demonstrating that these cells are mandatory for the development of AD. In contrast, CD4+ T cell-depleted mice develop a severe form of eczema. Furthermore, adoptive transfer of CD8+ T cells from sensitized mice into naive recipient mice leads to skin inflammation soon after allergen exposure. These data indicate that allergen-primed CD8+ T cells are required for the development of AD-like lesions in mice.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by institutional grants from Institut National de la Santé et de la Recherche Médicale, Université Claude Bernard Lyon 1, and Hospices Civils de Lyon and by a grant from the Centre de Recherche sur la Peau et les Épithélium de Revêtement, Pierre Fabre Laboratories (Castres, France).
2 Address correspondence and reprint requests to Dr. Jean-François Nicolas, Institut National de la Santé et de la Recherche Médicale Unité 503, LInstitut Fédératif de Recherche 128, 21 av Tony Garnier, 69375 Lyon, France. E-mail address: jean-francois.nicolas{at}chu-lyon.fr or nicolas{at}cervi-lyon.inserm.fr
3 Abbreviations used in this paper: AD, atopic dermatitis; FasL, Fas ligand; CLA, cutaneous lymphocyte-associated Ag; Der f, Dermatophagoides farinae; Der p, Dermatophagoides pteronyssinus; LN, lymph node; SFC, spot-forming cell; TARC, thymus- and activation-regulated chemokine.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |